Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode

• Published in: Schizophrenia research Vol. 83; no. 1; pp. 53 - 63
• Main Authors: Perkins, Diana O., Johnson, Jacqueline L., Hamer, Robert M., Zipursky, Robert B., Keefe, Richard S., Centorrhino, Franca, Green, Alan I., Glick, Ira B., Kahn, Rene S., Sharma, Tonmoy, Tohen, Mauricio, McEvoy, Joseph P., Weiden, Peter J., Lieberman, Jeffrey A.
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier B.V 01.03.2006; Elsevier Science
• Subjects: Adherence; Adult; Adult and adolescent clinical studies; Antipsychotic Agents - adverse effects; Antipsychotic Agents - therapeutic use; Attitude to Health; Benzodiazepines - adverse effects; Benzodiazepines - therapeutic use; Biological and medical sciences; Chronic Disease; Compliance; Double-Blind Method; Female; First episode; Haloperidol - adverse effects; Haloperidol - therapeutic use; HBM1; Health belief model; Humans; Male; Medical sciences; Models, Psychological; Neuropharmacology; Patient Compliance - psychology; Pharmacology. Drug treatments; Proportional Hazards Models; Prospective Studies; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychopharmacology; Psychoses; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenia - drug therapy; Schizophrenic Psychology; Adherence; Schizophrenia; First episode; Compliance; Health belief model; HBM1; Belief; Human; Psychotropic; Neuroleptic; Health; Adhesion; Drug compliance; Psychosis; Chemotherapy; Treatment; HBMI; Models; Predictive factor

Many patients recovering from a first psychotic episode will discontinue medication against medical advice, even before a 1-year treatment course is completed. Factors associated with treatment adherence in patients with chronic schizophrenia include beliefs about severity of illness and need for tr...